Review: taking Phendimetrazine tartrate and Synthroid together


Summary

Drug interactions are reported among people who take Phendimetrazine tartrate and Synthroid together. This review analyzes the effectiveness and drug interactions between Phendimetrazine tartrate and Synthroid. It is created by eHealthMe based on reports of 114 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Phendimetrazine tartrate and Synthroid >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Phendimetrazine Tartrate

Phendimetrazine tartrate has active ingredients of phendimetrazine tartrate. It is often used in weight loss. (latest outcomes from Phendimetrazine tartrate 149 users)

Synthroid

Synthroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. (latest outcomes from Synthroid 107,543 users)

On Aug, 30, 2016

114 people who take Phendimetrazine Tartrate, Synthroid are studied.


Number of reports submitted per year:

Phendimetrazine tartrate and Synthroid drug interactions.

Drug effectiveness over time:

Phendimetrazine Tartrate:
  • < 1 month: 0.0% - (0 of 3 people)
  • 1 - 6 months: 25.0% - (1 of 4 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Synthroid:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 3 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Phendimetrazine Tartrate:
  • female: 14.0% - (1 of 7 people)
  • male: 0.0% - (0 of 0 people)
Synthroid:
  • female: 11.0% - (1 of 9 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Phendimetrazine Tartrate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 4 people)
  • 40-49: 33.0% - (1 of 3 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Synthroid:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 5 people)
  • 40-49: 25.0% - (1 of 4 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • blood pressure decreased
  • dehydration
  • injection site pain
  • polyp
  • renal function test abnormal
  • vomiting
  • injection site haematoma
  • acute respiratory failure
  • cardiac failure
  • depression
1 - 6 months:
  • fatigue
1 - 2 years:
  • convulsion
  • haemorrhagic cerebral infarction
  • headache
  • pneumonia aspiration
  • transverse sinus thrombosis
  • confusional state
2 - 5 years:
  • abdominal pain upper
  • dyspnoea
  • fatigue
  • pulmonary embolism
  • pulmonary infarction
5 - 10 years:
  • blindness
  • retinal vascular thrombosis
  • vitreous haemorrhage
  • visual acuity reduced
not specified:
  • dyspnoea
  • chest pain
  • diarrhoea
  • syncope
  • constipation
  • flatulence
  • palpitations
  • nausea
  • dehydration
  • abdominal pain upper

Most common drug interactions by gender *:

female:
  • dyspnoea
  • chest pain
  • flatulence
  • palpitations
  • vomiting
  • nausea
  • abdominal pain upper
  • constipation
  • depression
  • injection site pain
male:
  • syncope
  • pneumonia
  • diverticulitis
  • faecal incontinence
  • non-small cell lung cancer metastatic
  • pericardial effusion
  • pneumomediastinum
  • urinary incontinence
  • ventricular extrasystoles
  • bone density decreased

Most common drug interactions by age *:

10-19:
  • confusional state
  • convulsion
  • haemorrhagic cerebral infarction
  • headache
  • pneumonia aspiration
  • transverse sinus thrombosis
30-39:
  • abdominal pain upper
  • back pain
  • biliary colic
  • chest pain
  • cholelithiasis
  • dyspnoea
  • injury
  • nausea
  • cholecystitis chronic
  • abdominal distension
40-49:
  • chest pain
  • fatigue
  • pulmonary embolism
  • back pain
  • cerebrovascular accident
  • constipation
  • crying
  • deep vein thrombosis
  • depression
  • drug ineffective
50-59:
  • mitral valve incompetence
  • oedema peripheral
  • palpitations
  • tricuspid valve incompetence
  • pancreatitis
  • bronchitis chronic
  • chest pain
  • haemorrhagic stroke
  • hemiparesis
  • hepatitis
60+:
  • dyspnoea
  • dehydration
  • syncope
  • vomiting
  • diarrhoea
  • pericardial effusion
  • pneumonia
  • injection site haematoma
  • injection site pain
  • constipation

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Phendimetrazine tartrate and Synthroid?

Can you answer these questions?

More questions for: Phendimetrazine tartrate, Synthroid

You may be interested in these reviews

More reviews for: Phendimetrazine tartrate, Synthroid

On eHealthMe, Phendimetrazine tartrate (phendimetrazine tartrate) is often used to treat weight loss. Synthroid (levothyroxine sodium) is often used to treat hypothyroidism. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.